Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vaping | 1 | 2020 | 436 | 0.50 | Why? |
| Lung Diseases, Interstitial | 1 | 2020 | 1476 | 0.37 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2020 | 1380 | 0.36 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.33 | Why? |
| Blood Coagulation | 1 | 2020 | 2768 | 0.32 | Why? |
| Acute Kidney Injury | 2 | 2021 | 5762 | 0.26 | Why? |
| Complement C4 | 1 | 2020 | 86 | 0.20 | Why? |
| Pneumonia | 1 | 2020 | 5652 | 0.20 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2020 | 170 | 0.20 | Why? |
| Lupus Nephritis | 1 | 2020 | 113 | 0.19 | Why? |
| Antibodies, Antinuclear | 1 | 2020 | 234 | 0.18 | Why? |
| Mycophenolic Acid | 1 | 2020 | 383 | 0.17 | Why? |
| Habits | 1 | 2020 | 334 | 0.17 | Why? |
| Complement C3 | 1 | 2020 | 271 | 0.17 | Why? |
| Cardiac Tamponade | 1 | 2020 | 165 | 0.16 | Why? |
| Herpesvirus 4, Human | 1 | 2020 | 387 | 0.16 | Why? |
| Tomography, X-Ray Computed | 2 | 2020 | 25144 | 0.15 | Why? |
| Epstein-Barr Virus Infections | 1 | 2020 | 366 | 0.15 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2020 | 398 | 0.14 | Why? |
| DNA | 1 | 2020 | 778 | 0.13 | Why? |
| Multicenter Studies as Topic | 1 | 2021 | 2437 | 0.13 | Why? |
| Pneumonia, Bacterial | 1 | 2020 | 843 | 0.12 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.12 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.12 | Why? |
| Disseminated Intravascular Coagulation | 1 | 2021 | 994 | 0.12 | Why? |
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 800 | 0.11 | Why? |
| Arrhythmias, Cardiac | 2 | 2021 | 2510 | 0.10 | Why? |
| Cost-Benefit Analysis | 1 | 2020 | 2259 | 0.10 | Why? |
| Enzyme Inhibitors | 1 | 2020 | 1881 | 0.09 | Why? |
| Methylprednisolone | 1 | 2020 | 2107 | 0.09 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.09 | Why? |
| Lymphopenia | 1 | 2020 | 2669 | 0.08 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.08 | Why? |
| Cough | 1 | 2020 | 4891 | 0.07 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.07 | Why? |
| Gastrointestinal Diseases | 1 | 2020 | 2580 | 0.07 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.07 | Why? |
| Antirheumatic Agents | 1 | 2020 | 3023 | 0.07 | Why? |
| Betacoronavirus | 5 | 2020 | 204454 | 0.07 | Why? |
| Glucocorticoids | 1 | 2020 | 4431 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.06 | Why? |
| Radiography, Thoracic | 1 | 2020 | 5486 | 0.06 | Why? |
| Fever | 1 | 2020 | 7795 | 0.06 | Why? |
| Venous Thromboembolism | 1 | 2021 | 4273 | 0.06 | Why? |
| Pandemics | 6 | 2020 | 389249 | 0.05 | Why? |
| Physicians | 1 | 2020 | 4214 | 0.05 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.05 | Why? |
| Stenotrophomonas maltophilia | 1 | 2020 | 63 | 0.05 | Why? |
| Risk Assessment | 2 | 2021 | 25439 | 0.05 | Why? |
| Humans | 10 | 2021 | 930598 | 0.04 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Health Services Accessibility | 1 | 2020 | 10697 | 0.04 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Intensive Care Units | 1 | 2021 | 29594 | 0.03 | Why? |
| Observational Studies as Topic | 1 | 2021 | 1887 | 0.03 | Why? |
| United States | 1 | 2020 | 46150 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.03 | Why? |
| Lung | 1 | 2020 | 31049 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| Retrospective Studies | 1 | 2021 | 105322 | 0.02 | Why? |
| Young Adult | 1 | 2020 | 93724 | 0.02 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Male | 3 | 2021 | 367725 | 0.02 | Why? |
| Female | 3 | 2021 | 380317 | 0.02 | Why? |
| Transplant Recipients | 1 | 2020 | 4982 | 0.02 | Why? |
| Immunocompromised Host | 1 | 2020 | 5150 | 0.02 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.01 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.01 | Why? |
| Kidney Transplantation | 1 | 2020 | 5397 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Prevalence | 1 | 2021 | 25773 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2020 | 10083 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Prognosis | 1 | 2021 | 32490 | 0.01 | Why? |
| Hospital Mortality | 1 | 2021 | 22087 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2020 | 15421 | 0.01 | Why? |
| Middle Aged | 2 | 2021 | 270681 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Aged | 1 | 2021 | 215776 | 0.00 | Why? |
Kichloo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_